Virtu KCG Holdings’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-11,006
Closed 4284
2015
Q4
$0 Sell
11,006
-10,042
-48% -$111K ﹤0.01% 4394
2015
Q3
$40K Buy
+21,048
New +$55.5K ﹤0.01% 3049
2015
Q1
Sell
-3,721
Closed -$52K 4559
2014
Q4
$52K Buy
3,721
+1,947
+110% +$27.8K ﹤0.01% 3423
2014
Q3
$22K Buy
+1,774
New +$24.5K ﹤0.01% 3465

Other funds holding KBIO

Virtu KCG Holdings's KBIO Position: Q1 2016 in Review

Virtu KCG Holdings sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 11,006 shares.

Virtu KCG Holdings first reported a position in KBIO in Q3 2014 and held it in 4 quarters. The position peaked at $52K in Q4 2014. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • Virtu KCG Holdings reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 11,006 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016.
  • Virtu KCG Holdings first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $52K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Virtu KCG Holdings's 13F filing for Q1 2016, filed 13 May 2016.